A wearable is not a chemical quality test. Even when a physiological measurement changes after an exposure, it cannot identify the substance in a vial, quantify its concentration or establish how it was stored. The inference “the number changed, so the product weakened” skips several unproven steps.
The phase 2 trial tracked heart rate as a safety observation, not as a validated home assay of retatrutide potency. A measurement collected for that purpose cannot be repurposed into a batch-testing method simply because readers can collect a superficially similar number on a watch.
There are two separate problems to investigate. One is whether the person is experiencing a clinically important change. The other is whether the actual product is what its label claims. A medical history and appropriate clinical assessment address the first. Documentation and suitable independent product-quality evidence address the second. One does not substitute for the other.
The same reasoning applies to subjective markers such as warmth, appetite or a familiar side effect. A noticeable sensation does not prove purity, and the absence of that sensation does not prove degradation. Trying additional material to “test” the hypothesis creates another exposure without resolving the original uncertainty.
FDA’s warning about unapproved products is relevant because a research label does not establish clinical suitability. A sponsor's trial does not verify the preparation a consumer has obtained. Likewise, a certificate discussed online must not be assumed to settle every question about the vial in hand, its provenance or its handling.
If a person has already used an uncertain product, the useful clinical information is the exact label, available documentation, timing of exposure and symptoms, not a conclusion about potency inferred from a graph. Do not self-adjust or repeat exposure to make a wearable response look familiar. Concerning symptoms deserve assessment regardless of whether the device trend seems reassuring. The key distinction is simple: a physiological signal may be relevant to health, but it cannot do the work of an analytical test or establish that an unapproved product is safe to use.